Simultaneous Occurrence of t(8;21) and del(5q) in Myeloid Neoplasms

  • Katharina Clodi
  • Alexander Gaiger
  • Christine Peters
  • Janina Boguslawska-Jaworska
  • Ulrich Jäger
  • Oskar A. Haas
Conference paper
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 37)


The translocation t(8;21)(q22;q22) and the deletion of the long arm of chromosome 5, del(5q), are two acquired chromosome abnormalities which characterize distinct biological entities of hematologic neoplasms. We have observed two patients, a 9 year old girl with refractory anemia with excess of blasts in transformation (RAEB-T) overting to M2-AML and a 50 year old woman with refractory anemia with excess of blasts (RAEB) in whom both abnormalities concurred in the same cell clone. After chemotherapy the girl underwent a successful allogeneic bone marrow transplantation (BMT) from her sister and has remained in complete remission two years after diagnosis. The other patient received only erythrocyte transfusions and has been in stable condition for three years. In addition, a 33 year old man with a complex translocation t(5;8;21)(q13;q13;q11) is presented for comparison. His hematologic findings and clinical course was similar to that of other patients with a t(8;21). We conclude that in cases with two specific karyotype changes the biological features typically associated with one or the other chromosome abnormality may dominate the phenotype. It remains unclear whether the clinical and hematological appearance of the disease is determined by the abnormality which occurs first or by the one which predominates.


Acute Promyelocytic Leukemia Macrocytic Anemia Acute Nonlymphocytic Leukemia Complex Translocation Erythrocyte Transfusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    (1990) Acute myelogenous leukemia with an 8; 21 translocation. A report on 148 cases from the Groupe Francais de Cytogenetique Hema-tologique. Cancer Genet Cytogenet 44:169–179Google Scholar
  2. 2.
    Hurwitz CA, Raimondi SC, Head D, et al (1992) Distinctive immunophenotypic features of t(8; 21)(q22; q22) acute myeloblastic leukemia in children. Blood 80: 3182–3188PubMedGoogle Scholar
  3. 3.
    Kita K, Nakase K, Miwa H, et al (1992) Phenotypical characteristics of acute myelocytic leukemia associated with the t(8; 21)(q22; q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 80: 470–477PubMedGoogle Scholar
  4. 4.
    van den Berghe H, Vermaelen C, Meccuci C, Barbieri D, Tricot G (1985) The 5q- anomaly. Cancer Genet Cytogenet 17:189–255PubMedCrossRefGoogle Scholar
  5. 5.
    Mecucci C, Noens L, Aventin A, Testoni N, van den Berghe H (1988) Philadelphia positive acute myelo-monocytic leukemia with inversion of chromosome 16 and eosinobasophils. Am J Hematol 27: 69–71PubMedCrossRefGoogle Scholar
  6. 6.
    Li YS, Hayhoe FGJ (1989) A case of Ph-positive acute non-lymphocytic leukemia with inv(16). Chong Hua I Hsnech Tsa Chik 69:119–120Google Scholar
  7. 7.
    Lai JL, Fenaux P, Zandecki M, et al (1987) Promyelocytic blast crisis of Philadelphia-positive thrombocythemia with translocations (9;22) and (15;17). Cancer Genet Cytogenet 29:311–314PubMedCrossRefGoogle Scholar
  8. 8.
    Hogge DM, Misawa S, Schiffer CA, Testa JR (1984) Promyelocytic blast crisis in chronic granulocytic leukemai with 15;17 tranlocation. Leuk Res 8: 1019–1023PubMedCrossRefGoogle Scholar
  9. 9.
    Berger R, Bernheim A, Daniel MT, Flandrin G (1983) t(15;17) in a promyelocytic form of chronic myeloid leukemia blastic crisis. Cancer Genet Cytogenet 8:149–152PubMedCrossRefGoogle Scholar
  10. 10.
    Francesconi D, Pasquali F (1978) 8/21 translocation, loss of the Y chromosome and Philadelphias chromosome. Br J Haematol 38:149–150PubMedCrossRefGoogle Scholar
  11. 11.
    Dallorso S, Sessarego M, Garre ML, Haupt R, Pasino M, Sansone R (1990) Secondary acute promyelocytic leukemia with t(8; 21) and t(9; 22) at onset and loss of the Philadelphia chromosome at relapse. Cancer Genet Cytogenet 47: 41–46PubMedCrossRefGoogle Scholar
  12. 12.
    Xue YQ, Guo Y, Lu DR, et al (1991) A case of basophilic leukemia bearing simultaneous translocations t(8;21) and t(9;22). Cancer Genet Cytogenet 51: 215–221PubMedCrossRefGoogle Scholar
  13. 13.
    Dastugue N, Demur C, Pris F, et al (1988) Association of the Philadelphia chromosome and 5q- in secondary blood disorder. Cancer Genet Cytogenet 30: 253–259PubMedCrossRefGoogle Scholar
  14. 14.
    Moir DJ, Pearson J, Buckle VJ (1984) Acute promyelocytic transformations in a case of acute myelomonocytic leukemia. Cancer Genet Cytogenet 12:359–364PubMedCrossRefGoogle Scholar
  15. 15.
    Charrin C, Ritouet D, Campos L, et al (1992) Association of t(15; 17) and t(8; 21) in the initial phase of an acute promyelocytic leukemia. Cancer Genet Cytogenet 58:177–180PubMedCrossRefGoogle Scholar
  16. 16.
    Prigogina EL, Fleischman EW, Puchkova GP, et al (1986) Chromosomes in acute nonlymphocytic leukemia. Hum Genet 73:137–146PubMedCrossRefGoogle Scholar
  17. 17.
    Bernstein R, Pinto MR, Morcom G, et al (1982) Karyotype analysis in acute nonlymphocytic leukemia (ANLL): comparison with ethnic group, age, morphology, and survival. Cancer Genet Cytogenet 6:187–199PubMedCrossRefGoogle Scholar
  18. 18.
    Battaglia D, Dube I, Pinkerton P, Senn J (1989) Acquisition of additional primary chromosome abnormalities in the course of karyotype evolution in a case of FAB-M2 acute leukemia. Cancer Genet Cytogenet 40:105–110PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • Katharina Clodi
    • 1
  • Alexander Gaiger
    • 2
  • Christine Peters
    • 1
  • Janina Boguslawska-Jaworska
    • 3
  • Ulrich Jäger
    • 2
  • Oskar A. Haas
    • 1
  1. 1.St. Anna Children’s HospitalChildren’s Cancer Research Institute (CCRI)ViennaAustria
  2. 2.Dept.of HematologyUniversity Medical ClinicViennaAustria
  3. 3.Dept.of PediatricsMedical AcademyWroclawPoland

Personalised recommendations